Deccan Transcon Leasing Limited (NSE:DECCANTRAN)
31.75
-0.70 (-2.16%)
At close: Aug 1, 2025
Regulus Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Cash & Equivalents | 43.11 | 30.63 | 35.1 | 10.76 | 3.76 | Upgrade |
Short-Term Investments | - | 1.49 | 1.5 | 1.68 | - | Upgrade |
Cash & Short-Term Investments | 43.11 | 32.12 | 36.6 | 12.44 | 3.76 | Upgrade |
Cash Growth | 34.20% | -12.23% | 194.27% | 231.12% | -60.10% | Upgrade |
Accounts Receivable | 679.27 | 416.01 | 255.27 | 203.69 | 182.71 | Upgrade |
Other Receivables | - | 17.98 | 5.18 | 0.83 | 3.15 | Upgrade |
Receivables | 679.27 | 433.99 | 260.45 | 204.52 | 185.86 | Upgrade |
Prepaid Expenses | - | 2.42 | 7.43 | 0.77 | - | Upgrade |
Other Current Assets | 77.56 | 22.74 | 3.91 | 2.92 | 2.86 | Upgrade |
Total Current Assets | 799.93 | 491.28 | 308.39 | 220.65 | 192.48 | Upgrade |
Property, Plant & Equipment | 637.24 | 225.38 | 183.05 | 142.61 | 124.49 | Upgrade |
Long-Term Investments | 54.17 | 40.61 | 27.78 | 13.28 | 13 | Upgrade |
Other Intangible Assets | 9.54 | 9.69 | 1.85 | 0.8 | 0.68 | Upgrade |
Other Long-Term Assets | 8.98 | 5.2 | 19.7 | 15.12 | 13.45 | Upgrade |
Total Assets | 1,510 | 772.16 | 540.77 | 392.46 | 344.1 | Upgrade |
Accounts Payable | 93.45 | 93.7 | 82.86 | 127.03 | 157.53 | Upgrade |
Accrued Expenses | 17.94 | 15.74 | 5.79 | 5.57 | 2.04 | Upgrade |
Short-Term Debt | 188.93 | 81.22 | 62.46 | 0.41 | - | Upgrade |
Current Portion of Long-Term Debt | - | 31.28 | 29.51 | 22.94 | - | Upgrade |
Current Income Taxes Payable | - | 30.16 | 10.23 | 3.5 | 4.53 | Upgrade |
Other Current Liabilities | 93.31 | 10.83 | 20.36 | 12.58 | 1.97 | Upgrade |
Total Current Liabilities | 393.63 | 262.93 | 211.21 | 172.04 | 166.07 | Upgrade |
Long-Term Debt | 137.46 | 118.45 | 85.58 | 75.63 | 30.03 | Upgrade |
Long-Term Leases | - | - | - | - | 60.4 | Upgrade |
Long-Term Deferred Tax Liabilities | 13.29 | 12.05 | 9.82 | 8.27 | 5.88 | Upgrade |
Other Long-Term Liabilities | - | - | - | - | -0 | Upgrade |
Total Liabilities | 549.5 | 398.41 | 308.63 | 257.44 | 262.39 | Upgrade |
Common Stock | 227.23 | 171.99 | 22 | 22 | 20 | Upgrade |
Retained Earnings | - | - | - | - | 51.02 | Upgrade |
Comprehensive Income & Other | 666.26 | 150.14 | 180.83 | 98.76 | 9.2 | Upgrade |
Total Common Equity | 893.5 | 322.13 | 202.83 | 120.76 | 80.23 | Upgrade |
Minority Interest | 66.85 | 51.61 | 29.31 | 14.27 | 1.48 | Upgrade |
Shareholders' Equity | 960.35 | 373.75 | 232.14 | 135.03 | 81.71 | Upgrade |
Total Liabilities & Equity | 1,510 | 772.16 | 540.77 | 392.46 | 344.1 | Upgrade |
Total Debt | 326.39 | 230.96 | 177.55 | 98.98 | 90.43 | Upgrade |
Net Cash (Debt) | -283.28 | -198.83 | -140.95 | -86.55 | -86.68 | Upgrade |
Net Cash Per Share | -14.11 | -11.56 | -8.36 | -5.13 | -6.65 | Upgrade |
Filing Date Shares Outstanding | 22.66 | 17.2 | 16.87 | 16.87 | 15.33 | Upgrade |
Total Common Shares Outstanding | 22.66 | 17.2 | 16.87 | 16.87 | 15.33 | Upgrade |
Working Capital | 406.3 | 228.34 | 97.18 | 48.61 | 26.4 | Upgrade |
Book Value Per Share | 39.43 | 18.73 | 12.03 | 7.16 | 5.23 | Upgrade |
Tangible Book Value | 883.96 | 312.44 | 200.98 | 119.96 | 79.55 | Upgrade |
Tangible Book Value Per Share | 39.01 | 18.17 | 11.92 | 7.11 | 5.19 | Upgrade |
Buildings | - | 34.05 | 34.05 | - | - | Upgrade |
Machinery | - | 254.84 | 195.55 | 177.64 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.